American Century Companies Inc Akebia Therapeutics, Inc. Transaction History

American Century Companies Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$2.92 - $5.06 $416,047 - $720,958	-142,482 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.22 - $3.78 $239,693 - $408,126	107,970 Added 312.85%	142,482 $399,000
Q3 2020 Nov 13, 2020	BUY	$2.39 - $13.08 $29,119 - $159,366	12,184 Added 54.57%	34,512 $87,000
Q2 2020 Aug 13, 2020	SELL	$6.67 - $13.58 $371,072 - $755,496	-55,633 Reduced 71.36%	22,328 $303,000
Q1 2020 May 14, 2020	BUY	$4.1 - $10.24 $319,640 - $798,320	77,961 New	77,961 $591,000
Q2 2019 Aug 14, 2019	SELL	$4.1 - $8.05 $739,976 - $1.45 Million	-180,482 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.41 - $8.73 $976,407 - $1.58 Million	180,482 New	180,482 $0
Q3 2018 Nov 02, 2018	SELL	$7.44 - $10.65 $2.56 Million - $3.67 Million	-344,447 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$9.15 - $11.34 $1.43 Million - $1.77 Million	-156,524 Reduced 31.24%	344,447 $3.44 Million
Q1 2018 May 03, 2018	BUY	$9.53 - $15.68 $1.41 Million - $2.32 Million	147,860 Added 41.87%	500,971 $4.77 Million
Q4 2017 Feb 02, 2018	BUY	$14.24 - $19.59 $1.96 Million - $2.69 Million	137,567 Added 63.82%	353,111 $5.25 Million
Q3 2017 Nov 01, 2017	BUY	$13.06 - $19.67 $2.82 Million - $4.24 Million	215,544	215,544 $4.24 Million

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.